ArticleLeukemia2017

Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth.

J Delgado-Calle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.